Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer

BACKGROUND: Intermediate-risk prostate cancer (PCa) is usually treated by a combination of external beam radiation therapy (EBRT) and a short course of androgen deprivation therapy (ADT). ADT is associated with multiple side effects, including weight gain, loss of libido, and hot flashes. In contras...

Descripción completa

Detalles Bibliográficos
Autores principales: Lara, Pedro C., Rodríguez-Melcón, Juan I., Palacios-Eito, Amalia, Lozano, Antonio, Hervás-Morón, Asunción, Villafranca, Elena, Gómez-Iturriaga, Alfonso, Sancho, Gemma, Maldonado, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329530/
https://www.ncbi.nlm.nih.gov/pubmed/35912190
http://dx.doi.org/10.3389/fonc.2022.891886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329530/
https://www.ncbi.nlm.nih.gov/pubmed/35912190
http://dx.doi.org/10.3389/fonc.2022.891886

Ejemplares similares